Who funds RNA therapeutics research?

We count 117 funded RNA therapeutics projects, active between 2021 and 2033, from 6 funders. The most came from EU · ERC (43 projects), EU · MSCA (26 projects) and Wellcome (16 projects). The median award is $1.6M, across the 113 of 117 projects that list an amount.

Funded projects

117

Funders

6

Median award

$1.6M

Open calls now

0

Top funders of RNA therapeutics research

Projects whose title or summary mentions RNA therapeutics. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open RNA therapeutics funding calls

No open call mentions RNA therapeutics in our listings today. We add new calls twice a day; create a free account to get an alert when one opens.

Funded RNA therapeutics projects

A sample, latest start first, at most three per program.

• From genesis to destruction: how does transcription initiation base selection regulate mRNA fate in development and tumorigenesis
  Wellcome · £3,103,102 · ends 2033
• Deciphering neuronal RBP regulation of mRNA transport and translation in synaptic plasticity
  Wellcome · £2,682,906 · ends 2032
• Defining the spatiotemporal gene expression dynamics controlling embryonic patterning
  Wellcome · £3,627,212 · ends 2031
• CAREER: Multiplexed mRNA detection at nanometer resolution
  NSF · BIO · $1,098,937 · ends 2031
• CAREER: Mathematical inference and analysis of spatio-temporal RNA transport and organization in development
  NSF · MPS · $505,185 · ends 2031
• From mechanism to clinical translation: Understanding the off- and on-target toxicities of nucleic-acid-dependent therapeutics
  UKRI · MRC · £3,437,107 · ends 2030
• Center for Multi-Scale Analysis of the Human Epitranscriptome
  NIH · NHGRI · $10,044,467 · ends 2030
• Post-transcriptional gene regulation
  NIH · NIGMS · $3,781,795 · ends 2030
• Transforming HIV vaccine design with a hybrid technology that leverages features of mRNA and protein nanoparticle platforms
  NIH · NIAID · $3,559,750 · ends 2029
• Defining short RNA therapeutics that combat TDP-43 proteinopathy connected to AD and ADRDs.
  NIH · NIA · $3,360,074 · ends 2029

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “mrna or rna therapeutics or sirna”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.